Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.99 | N/A |
PEG Ratio (TTM) | -0.14 | N/A |
P/S Ratio (TTM) | 1.02 | N/A |
P/B Ratio (TTM) | 1.49 | N/A |
P/FCF Ratio (TTM) | -1.51 | N/A |
Price to 5YR AVG Earnings Ratio | -1.64 | N/A |
Price to 5YR AVG FCF Ratio | -2.22 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -41.67% | N/A |
ROE (TTM) | -171.81% | N/A |
Net Profit Margin (TTM) | -67.55% | N/A |
ROIC 5YR AVG | -59.22% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 6.63% | -36.58% | -1,695.93% |
Revenue | -3.67% | 104.82% | 85.31% |
Net Income | -4.97% | -80.49% | -55.54% |
Cash Flow | -208.33% | -53.73% | -45.34% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.41 | N/A |
Quick Ratio (TTM) | 0.34 | N/A |
D/E Ratio (TTM) | 0.55 | N/A |
Interest Coverage (TTM) | -25.40 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -1.67 | N/A |
Shares Outstanding Growth 5YR AVG | 2.03% | N/A |